Erica Galbreath-Zuehlke

Erica Galbreath-Zuehlke currently serves as Senior Director of Global Oncology Medical Affairs Governance at Daiichi Sankyo, Inc. since August 2023. With a career spanning over two decades at Novartis, beginning in November 2001, Erica's roles have included Global Program Quality Lead, Associate Director of Oncology Quality Assurance, Global Head of Trial Management Process Control, Program Allocation and Recruitment Manager, Global Clinical Submission Manager, and Senior Compliance Specialist. Prior experience includes a brief tenure at Hoffman La Roche Pharmaceuticals as a Country Clinical Operations Associate and positions at Boehringer Ingelheim Pharmaceuticals as a Medical Research Associate and Assistant. Erica also worked as a Clinical Scientist and Cytogenetic Technologist Consultant at Dianon System. Educational qualifications include a Master of Public Health from New York Medical College and a Bachelor of Science in Biology from the State University of New York Cortland.